|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
2.370 -0.020 (-0.837%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Turnover | 784,694 | -10.478% | 876,535 | 828,541 | 899,359 | 655,825 |
| Cost of Sales | (128,434) | 31.146% | (97,932) | (89,742) | (88,897) | (69,181) |
| Gross Profit | 656,260 | -15.713% | 778,603 | 738,799 | 810,462 | 586,644 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (161) | (1,950) | (579) | 0 | |
| Profit / (Loss) before Taxation | 147,968 | -27.315% | 203,573 | 197,380 | 204,855 | 162,701 | |
| Taxation | (37,248) | -7.279% | (40,172) | (39,940) | (35,044) | (23,470) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 110,720 | -32.240% | 163,401 | 157,440 | 169,811 | 139,231 | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Net Finance Costs / (Income) | (2,966) | 13.163% | (2,621) | (3,410) | 2,406 | 1,190 |
| Depreciation & Amortisation | 35,662 | 25.319% | 28,457 | 26,480 | 31,215 | 20,495 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 19.530 | -32.235% | 28.820 | 27.740 | 29.720 | 24.210 |
| DPS (cts) | 5.000 | -- | 7.000 | 6.000 | 4.500 | 4.000 |
| Dividend Payout Ratio (%) | 25.602% | -- | 24.289% | 21.629% | 15.141% | 16.522% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.504 | -- | 4.010 | 3.551 | 3.169 | 3.036 |
| Remarks: | Real time quote last updated: 07/08/2026 10:11 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 110,720 |
| %Change | -32.240% |
| EPS / (LPS) | HKD 0.195 |
| NBV Per Share ($) | HKD 4.504 |